Catalyst Wire Dossier Catalyst Wire Dossier

rgp120/HIV-1IIIB vaccine

recombinant gp120 HIV-1IIIB vaccine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rgp120/HIV-1IIIB vaccine, covering 2012-05-18 to 2012-05-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study) [Phase 1]

See pricing